News | August 14, 2022
Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr
The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022
The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka
Clean Max Auriga Power is a special purpose vehicle engaged in the business of production, supply and distribution of solar and wind or other renewable energy generation plant
The two plots are located in the heart of Gurugram close to Sectors 53 on the Golf Course Road and Sector 56 just minutes away from the other location
The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Subscribe To Our Newsletter & Stay Updated
